SYF vs TYRA · rev $11.19B vs $531.8M cap
SYF (SYF) versus Tyra Biosciences Inc (TYRA) — a side-by-side from cached financials, not a winner call.
SYF (SYF) common stock.
Tyra Biosciences Inc (TYRA) is a biotechnology company listed on US.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
TYRA does not have a complete income-statement cache yet.
SYF currently screens at market cap $0. TYRA currently screens at market cap $531.8M.
Not investment advice. Open the SYF and TYRA stock pages for the full models.
Not investment advice.